Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 13 studies | 38% ± 18% | |
microglial cell | 12 studies | 33% ± 14% | |
endothelial cell | 10 studies | 28% ± 14% | |
astrocyte | 9 studies | 27% ± 12% | |
fibroblast | 8 studies | 22% ± 7% | |
type II pneumocyte | 6 studies | 34% ± 7% | |
oligodendrocyte | 6 studies | 26% ± 10% | |
macrophage | 6 studies | 23% ± 5% | |
T cell | 5 studies | 24% ± 2% | |
endothelial cell of lymphatic vessel | 5 studies | 23% ± 5% | |
type I pneumocyte | 5 studies | 24% ± 5% | |
GABAergic neuron | 4 studies | 28% ± 11% | |
retinal pigment epithelial cell | 4 studies | 48% ± 13% | |
epithelial cell | 4 studies | 33% ± 12% | |
natural killer cell | 4 studies | 23% ± 4% | |
B cell | 3 studies | 20% ± 4% | |
CD4-positive, alpha-beta T cell | 3 studies | 18% ± 3% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
glutamatergic neuron | 3 studies | 36% ± 7% | |
monocyte | 3 studies | 22% ± 1% | |
lymphocyte | 3 studies | 28% ± 8% | |
goblet cell | 3 studies | 41% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 4100.88 | 966 / 966 | 100% | 24.99 | 525 / 527 |
stomach | 100% | 3963.19 | 359 / 359 | 99% | 24.02 | 283 / 286 |
breast | 100% | 3284.11 | 459 / 459 | 98% | 44.90 | 1100 / 1118 |
thymus | 100% | 4540.65 | 653 / 653 | 98% | 21.83 | 595 / 605 |
prostate | 100% | 2843.60 | 244 / 245 | 99% | 20.85 | 495 / 502 |
lung | 100% | 4237.85 | 578 / 578 | 98% | 28.84 | 1129 / 1155 |
pancreas | 97% | 1637.26 | 319 / 328 | 98% | 32.25 | 175 / 178 |
kidney | 100% | 2576.25 | 89 / 89 | 96% | 16.75 | 861 / 901 |
uterus | 100% | 1724.35 | 170 / 170 | 93% | 17.24 | 427 / 459 |
esophagus | 98% | 2696.06 | 1416 / 1445 | 95% | 19.12 | 173 / 183 |
brain | 92% | 1494.34 | 2438 / 2642 | 100% | 30.63 | 702 / 705 |
skin | 99% | 3466.18 | 1793 / 1809 | 90% | 11.90 | 427 / 472 |
bladder | 100% | 3131.57 | 21 / 21 | 86% | 16.30 | 431 / 504 |
ovary | 100% | 12006.18 | 180 / 180 | 81% | 9.97 | 348 / 430 |
adrenal gland | 100% | 4335.57 | 258 / 258 | 49% | 12.65 | 112 / 230 |
liver | 58% | 542.59 | 130 / 226 | 44% | 5.41 | 180 / 406 |
adipose | 100% | 3155.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4402.11 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3590.17 | 1332 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3924.59 | 922 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 14.32 | 44 / 45 |
heart | 98% | 1689.81 | 841 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 10.99 | 27 / 29 |
muscle | 77% | 832.73 | 618 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 43% | 3.62 | 34 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016266 | Biological process | O-glycan processing |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0004653 | Molecular function | polypeptide N-acetylgalactosaminyltransferase activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | GALNT10 |
Protein name | Polypeptide N-acetylgalactosaminyltransferase 10 Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10) GALNT10 protein |
Synonyms | |
Description | FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Has activity toward Muc5Ac and EA2 peptide substrates. |
Accessions | ENST00000377661.2 [Q86SR1-2] Q4G0E1 F2Z2M7 ENST00000425427.6 [Q86SR1-3] Q86SR1 ENST00000297107.11 [Q86SR1-1] ENST00000520647.5 |